Skip to main content
icon for Weed rescheduled by...?
Politics·Trump

Weed rescheduled by...?

icon for Weed rescheduled by...?
Politics·Trump

Weed rescheduled by...?

Mar 31

Mar 31

$764,777 Vol.

Mar 31, 2026
Polymarket

$764,777 Vol.

Polymarket

June 30

$340,918 Vol.

2%

December 31

$158,977 Vol.

27%

This market will resolve to "Yes" if marijuana is rescheduled down from I to any other level (or is unscheduled completely) by the Drug Enforcement Agency of the United States (https://www.dea.gov/drug-information/drug-scheduling), by June 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The primary resolution source for this market will be official information from the US government, however a consensus of credible reporting will also be used.This market will resolve to "Yes" if marijuana is rescheduled down from I to any other level (or is unscheduled completely) by the Drug Enforcement Agency of the United States (https://www.dea.gov/drug-information/drug-scheduling), by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The primary resolution source for this market will be official information from the US government, however a consensus of credible reporting will also be used.This market will resolve to "Yes" if marijuana is rescheduled down from I to any other level (or is unscheduled completely) by the Drug Enforcement Agency of the United States (https://www.dea.gov/drug-information/drug-scheduling), by March 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The primary resolution source for this market will be official information from the US government, however a consensus of credible reporting will also be used.The April 2026 Department of Justice order, issued under President Trump’s December 2025 executive directive, immediately moved FDA-approved cannabis products and state-licensed medical marijuana into Schedule III of the Controlled Substances Act, effective April 28. This partial rescheduling addressed research and tax barriers for qualifying medical operators while leaving broader botanical cannabis in Schedule I pending further review. An expedited DEA administrative hearing begins June 29, 2026, to evaluate full reclassification to Schedule III through formal rulemaking, including public input and potential litigation. Trader focus centers on the hearing timeline, any resulting final rule, and whether procedural or legal challenges extend the process beyond current expectations for completion.

This market will resolve to "Yes" if marijuana is rescheduled down from I to any other level (or is unscheduled completely) by the Drug Enforcement Agency of the United States (https://www.dea.gov/drug-information/drug-scheduling), by June 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".

The primary resolution source for this market will be official information from the US government, however a consensus of credible reporting will also be used.
Volume
$764,777
End Date
Mar 31, 2026
Market Opened
Feb 7, 2026, 5:04 PM ET

Resolver

0x65070BE91...
This market will resolve to "Yes" if marijuana is rescheduled down from I to any other level (or is unscheduled completely) by the Drug Enforcement Agency of the United States (https://www.dea.gov/drug-information/drug-scheduling), by June 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The primary resolution source for this market will be official information from the US government, however a consensus of credible reporting will also be used.
This market will resolve to "Yes" if marijuana is rescheduled down from I to any other level (or is unscheduled completely) by the Drug Enforcement Agency of the United States (https://www.dea.gov/drug-information/drug-scheduling), by June 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The primary resolution source for this market will be official information from the US government, however a consensus of credible reporting will also be used.This market will resolve to "Yes" if marijuana is rescheduled down from I to any other level (or is unscheduled completely) by the Drug Enforcement Agency of the United States (https://www.dea.gov/drug-information/drug-scheduling), by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The primary resolution source for this market will be official information from the US government, however a consensus of credible reporting will also be used.This market will resolve to "Yes" if marijuana is rescheduled down from I to any other level (or is unscheduled completely) by the Drug Enforcement Agency of the United States (https://www.dea.gov/drug-information/drug-scheduling), by March 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The primary resolution source for this market will be official information from the US government, however a consensus of credible reporting will also be used.The April 2026 Department of Justice order, issued under President Trump’s December 2025 executive directive, immediately moved FDA-approved cannabis products and state-licensed medical marijuana into Schedule III of the Controlled Substances Act, effective April 28. This partial rescheduling addressed research and tax barriers for qualifying medical operators while leaving broader botanical cannabis in Schedule I pending further review. An expedited DEA administrative hearing begins June 29, 2026, to evaluate full reclassification to Schedule III through formal rulemaking, including public input and potential litigation. Trader focus centers on the hearing timeline, any resulting final rule, and whether procedural or legal challenges extend the process beyond current expectations for completion.

This market will resolve to "Yes" if marijuana is rescheduled down from I to any other level (or is unscheduled completely) by the Drug Enforcement Agency of the United States (https://www.dea.gov/drug-information/drug-scheduling), by June 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".

The primary resolution source for this market will be official information from the US government, however a consensus of credible reporting will also be used.
Volume
$764,777
End Date
Mar 31, 2026
Market Opened
Feb 7, 2026, 5:04 PM ET

Resolver

0x65070BE91...
This market will resolve to "Yes" if marijuana is rescheduled down from I to any other level (or is unscheduled completely) by the Drug Enforcement Agency of the United States (https://www.dea.gov/drug-information/drug-scheduling), by June 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The primary resolution source for this market will be official information from the US government, however a consensus of credible reporting will also be used.

Related

icon for US Treasury transactions on blockchain by June 30?

US Treasury transactions on blockchain by June 30?

4%
icon for Will the 2026 Midterm Elections happen as scheduled?

Will the 2026 Midterm Elections happen as scheduled?

94%
icon for Will the U.S. invade Mexico in 2026?

Will the U.S. invade Mexico in 2026?

5%

Beware of external links.

Frequently Asked Questions

"Weed rescheduled by...?" is a prediction market on Polymarket with 3 possible outcomes where traders buy and sell shares based on what they believe will happen. The current leading outcome is " December 31" at 27%, followed by "June 30" at 2%. Prices reflect real-time crowd-sourced probabilities. For example, a share priced at 27¢ implies that the market collectively assigns a 27% chance to that outcome. These odds shift continuously as traders react to new developments and information. Shares in the correct outcome are redeemable for $1 each upon market resolution.

As of today, "Weed rescheduled by...?" has generated $764.8K in total trading volume since the market launched on Nov 5, 2025. This level of trading activity reflects strong engagement from the Polymarket community and helps ensure that the current odds are informed by a deep pool of market participants. You can track live price movements and trade on any outcome directly on this page.

To trade on "Weed rescheduled by...?," browse the 3 available outcomes listed on this page. Each outcome displays a current price representing the market's implied probability. To take a position, select the outcome you believe is most likely, choose "Yes" to trade in favor of it or "No" to trade against it, enter your amount, and click "Trade." If your chosen outcome is correct when the market resolves, your "Yes" shares pay out $1 each. If it's incorrect, they pay out $0. You can also sell your shares at any time before resolution if you want to lock in a profit or cut a loss.

The current frontrunner for "Weed rescheduled by...?" is " December 31" at 27%, meaning the market assigns a 27% chance to that outcome. The next closest outcome is "June 30" at 2%. These odds update in real-time as traders buy and sell shares, so they reflect the latest collective view of what's most likely to happen. Check back frequently or bookmark this page to follow how the odds shift as new information emerges.

The resolution rules for "Weed rescheduled by...?" define exactly what needs to happen for each outcome to be declared a winner — including the official data sources used to determine the result. You can review the complete resolution criteria in the "Rules" section on this page above the comments. We recommend reading the rules carefully before trading, as they specify the precise conditions, edge cases, and sources that govern how this market is settled.